Alimera Sciences Ltd., of Atlanta, said real-world data show that the majority of diabetic macular edema patients who received Iluvien (fluocinolone acetonide 190 mcg intravitreal implant in applicator) in routine clinical practice gained or maintained vision at 12 months.